Company intelligence / Profile preview

Pairwise

Durham, North Carolina, United Statespairwise.com ↗

Ownership: Private
Employees: ~125
Development stage: Commercial

Overview

Pairwise has commercialized gene-edited fruits such as seedless blackberries and pitless cherries using its proprietary CRISPR-based Fulcrum Platform. The company focuses on improving the nutritional value, convenience, and sustainability of produce. It licenses its technology to partners for further product development and commercialization.

Modalities: CRISPR-based technologyGene editing technology
Industry: Non-Drug Biotech

Partnerships

Corteva Agriscience (investor/collaborator)

Beyond the preview

Go deeper on Pairwise.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pairwise.

Explore the full profile